title: Characterizing the Covalent Targets of a Small Molecule Inhibitor of the Lysine Acetyltransferase P300.
abstract: C646 inhibits the lysine acetyltransferases (KATs) p300 and CBP and represents the most potent and selective small molecule KAT inhibitor identified to date. To gain insights into the cellular activity of this epigenetic probe, we applied chemoproteomics to identify covalent targets of the C646 chemotype. Modeling and synthetic derivatization was used to develop a clickable analogue (C646-yne) that inhibits p300 similarly to the parent compound and enables enrichment of bound proteins. LC-MS/MS identified the major covalent targets of C646-yne as highly abundant cysteine-containing proteins, and follow-up studies found that C646 can inhibit tubulin polymerization in vitro. Finally, we provide evidence that thiol reactivity of C646 may limit its ability to antagonize acetylation in cells. These findings should enable a more precise interpretation of studies utilizing C646 as a chemical probe of KAT activity and suggest that an underappreciated liability of electrophile-containing inhibitors is a reduction in their cellular potency due to consumption by abundant protein and metabolite thiol sinks.
authors.affiliation: Chemical Biology Laboratory, National Cancer Institute , Frederick, Maryland 21702, United States.
authors.forename: Jonathan H
authors.initials: JH
authors.lastname: Shrimp
authors.affiliation: Chemical Biology Laboratory, National Cancer Institute , Frederick, Maryland 21702, United States.
authors.forename: Alexander W
authors.initials: AW
authors.lastname: Sorum
authors.affiliation: Chemical Biology Laboratory, National Cancer Institute , Frederick, Maryland 21702, United States.
authors.forename: Julie M
authors.initials: JM
authors.lastname: Garlick
authors.affiliation: Chemical Biology Laboratory, National Cancer Institute , Frederick, Maryland 21702, United States.
authors.forename: Laura
authors.initials: L
authors.lastname: Guasch
authors.affiliation: Chemical Biology Laboratory, National Cancer Institute , Frederick, Maryland 21702, United States.
authors.forename: Marc C
authors.initials: MC
authors.lastname: Nicklaus
authors.affiliation: Chemical Biology Laboratory, National Cancer Institute , Frederick, Maryland 21702, United States.
authors.forename: Jordan L
authors.initials: JL
authors.lastname: Meier
keywords: Acetylation; PAINS; acetyltransferase; epigenetics; pan-assay interference; probes; reversible covalent inhibitor